Delivery Order SPE2DR25D3108-SPE2DR26F1PPF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Entecavir 0.5 mg tablets in a 30-count configuration. This is a firm fixed price delivery order with a ceiling value of $2,640.56 and an ultimate completion date of September 24, 2025. The award is not set-aside and represents a competitive award to AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania. The contract will be performed at the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,062.15 contract is for the delivery of Entecavir 0.5 milligram tablets to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $1,142.56. The order was competitively awarded without set-aside restrictions and is scheduled for completion by August 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Entecavir 0.5 mg tablets (30-count) valued at $2,795.02, with completion scheduled for November 13, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The performance location is the company's corporate office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Entecavir 0.5 mg tablets in quantities of 30 units. This contract, valued at $2,631.62, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,067.66 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of Entecavir 0.5 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military healthcare...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,532.79 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,150,864 units of the prescription medication Entecavir 0.5 mg tablets. This delivery order is a part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA. The IDC serves as the primary contract vehicle for...
- The Defense Logistics Agency awarded a $1,996.61 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Entecavir 0.5 mg tablets (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, consistent with AmerisourceBergen's typical federal procurement profile....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Entecavir 0.5 mg tablets (30-count packaging) with a ceiling value of $1,650.08 under a firm fixed price contract type. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,202.28 to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- SPE2DR25D3108Indefinite Delivery Contract
- SPE2DR25D3108-SPE2DR26F1PPFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count package) with a ceiling value of $1,335.97. The contract was awarded on November 17, 2025, with an ultimate completion date of November 18, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. The company maintains significant relationships with the Defense Health Agency and other government healthcare entities through the DLA Troop Support Medical contract, demonstrating its capability to fulfill federal pharmaceutical procurement requirements through competitive open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/17/25 |